PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 118 filers reported holding PROVENTION BIO INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,712,916 | +1587.2% | 320,038 | +640.0% | 0.00% | – |
| Q4 2022 | $457,142 | +217.5% | 43,249 | +35.4% | 0.00% | – |
| Q3 2022 | $144,000 | +11.6% | 31,952 | -1.0% | 0.00% | – |
| Q2 2022 | $129,000 | -50.6% | 32,278 | -9.4% | 0.00% | – |
| Q1 2022 | $261,000 | +22.5% | 35,618 | -6.0% | 0.00% | – |
| Q4 2021 | $213,000 | -3.6% | 37,876 | +9.9% | 0.00% | – |
| Q3 2021 | $221,000 | -29.2% | 34,473 | -6.9% | 0.00% | – |
| Q2 2021 | $312,000 | -35.4% | 37,028 | -19.5% | 0.00% | – |
| Q1 2021 | $483,000 | -18.5% | 45,993 | +31.4% | 0.00% | – |
| Q4 2020 | $593,000 | +7.6% | 34,996 | -18.6% | 0.00% | – |
| Q3 2020 | $551,000 | -16.5% | 43,002 | -8.1% | 0.00% | – |
| Q2 2020 | $660,000 | +177.3% | 46,793 | +81.1% | 0.00% | – |
| Q1 2020 | $238,000 | -23.5% | 25,835 | +24.0% | 0.00% | – |
| Q4 2019 | $311,000 | +270.2% | 20,839 | +68.5% | 0.00% | – |
| Q3 2019 | $84,000 | +663.6% | 12,369 | +334.0% | 0.00% | – |
| Q3 2018 | $11,000 | – | 2,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |